购物车
全部删除
您的购物车当前为空
别名 GSK J1
GSK-J1 是一种高效的 H3K27 组蛋白去甲基化酶抑制剂,在无细胞试验中对 JMJD3 (KDM6B) 和 UTX (KDM6A) 的 IC50 分别为 28 nM 和 53 nM,比其他测试的去甲基化酶选择性高 10 倍以上。

GSK-J1 是一种高效的 H3K27 组蛋白去甲基化酶抑制剂,在无细胞试验中对 JMJD3 (KDM6B) 和 UTX (KDM6A) 的 IC50 分别为 28 nM 和 53 nM,比其他测试的去甲基化酶选择性高 10 倍以上。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 149 | 现货 | |
| 5 mg | ¥ 332 | 现货 | |
| 10 mg | ¥ 534 | 现货 | |
| 25 mg | ¥ 863 | 现货 | |
| 50 mg | ¥ 1,560 | 现货 | |
| 100 mg | ¥ 2,610 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 588 | 现货 |
GSK-J1 相关产品
| 产品描述 | GSK-J1 is a highly potent H3K27 histone demethylase inhibitor with IC50 of 28 nM and 53 nM in cell-free assays for JMJD3 (KDM6B) and UTX (KDM6A), respectively, >10-fold selectivity over other tested demethylases. |
| 靶点活性 | JMJD3 (KDM6B):28 nM, UTX (KDM6A):53 nM |
| 体外活性 | 在HEK-293细胞中,GSK-J1抑制暂时转染的JMJD3和UTX的活性。GSK-J1还通过增加总核H3K27me3水平来抑制人初级巨噬细胞产生的TNF-α。[1] 在MC3T3-E1细胞中,GSK-J1抑制Runx2和Osterix表达以及ALP活性,并增加了全球H3K27me3的水平。[2] |
| 激酶实验 | Purified JmjD3 (1 μM) and UTX (3 μM) is incubated with 10 μM peptide [BiotinKAPRKQLATKAARK(me3 )SAPATGG] in 50 mM HEPES pH 7.5, 150 mM KCl, 50 μM (NH4)2SO4·FeSO4·Water, 1 mM 2-oxoglutarate, and 2 mM ascorbate (JmjD3, 3 minutes at 25°C; UTX, 20 minutes at 25°C) with various concentration of the inhibitor (0, 0.005, 0.01, 0.02, 0.05, 0.1 μM). 10 mM EDTA is added to stop the reaction. The reaction is desalted by zip tip and spotted on a MALDI plate with α-cyano-4-hydroxycinnamic acid MALDI matrix. Samples are analysed on a MALDI-TOF R system. |
| 别名 | GSK J1 |
| 分子量 | 389.45 |
| 分子式 | C22H23N5O2 |
| CAS No. | 1373422-53-7 |
| Smiles | OC(=O)CCNc1cc(nc(n1)-c1ccccn1)N1CCc2ccccc2CC1 |
| 密度 | 1.292 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | Ethanol: 38.9 mg/mL (99.88 mM), Sonication is recommended. DMSO: 38.9 mg/mL (99.88 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (5.14 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
Ethanol/DMSO
| |||||||||||||||||||||||||||||||
评论内容